Show Summary Details
Page of

Metabolic Bone Disease 

Metabolic Bone Disease
Metabolic Bone Disease

Ashok Bhalla

and Tehseen Ahmed

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2022. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 25 May 2022

The term ‘metabolic bone disease’ covers a wide variety of disorders that can ultimately lead to alteration in bone strength. The disorders can be both inherited and acquired. Abnormalities of calcium, phosphate, and/or vitamin D are commonly seen. However, the most common metabolic bone disorder is osteoporosis, in which the density and quality of bone architecture is adversely affected. Osteoporosis is a major health problem, with one in two women and one in five men over the age of 50 expected to sustain a fragility fracture in their remaining lifetime. As one might expect, this leads to significant morbidity and excess mortality. Osteoporosis can be expected to represent an increasing burden on health resources as life expectancy continues to increase. In this chapter, eight landmark papers have been chosen that cover various aspects of metabolic bone disease, but with a primary focus on osteoporosis.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.